Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole

Experimental Parasitology

Volumn 124, Issue 2, 2010, Pages 167-171

  López Muñoz, Rodrigo ^a   Faúndez, Mario ^b   Klein, Sebastián ^b   Escanilla, Sebastián ^b   Torres, Gloria ^a   Lee Liu, Dasfne ^a   Ferreira, Jorge ^a   Kemmerling, Ulrike ^a   Orellana, Myriam ^a   Morello, Antonio ^a   Ferreira, Arturo ^a   Maya, Juan D ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Aspirin; Benznidazole; Nifurtimox; Synergism; Trypanosoma cruzi

Indexed keywords

ACETYLSALICYLIC ACID; BENZNIDAZOLE; NIFURTIMOX; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; IC 50; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ANIMALS; ASPIRIN; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE INHIBITORS; DRUG SYNERGISM; INHIBITORY CONCENTRATION 50; MACROPHAGES; MICE; NIFURTIMOX; NITRIC OXIDE; NITROIMIDAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 73649109547     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.09.005     Document Type: Article

References (23)

1. Abdalla G.K., Faria G.E., Silva K.T., Castro E.C., Reis M.A., and Michelin M.A. Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection. Experimental Parasitology 118 (2008) 514-521
2. Anderson P.O., Knoben J.E., and Troutman W.G. Handbook of Clinical Drug Data (2002), McGraw-Hill Medical Pub. Division, New York
3. Borges M.M., Kloetzel J.K., Andrade Jr. H.F., Tadokoro C.E., Pinge-Filho P., and Abrahamsohn I. Prostaglandin and nitric oxide regulate TNF-alpha production during Trypanosoma cruzi infection. Immunology Letters 63 (1998) 1-8
4. Cardoni R.L., and Antunez M.I. Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections. Mediators of Inflammation 13 (2004) 235-240
5. Chou T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacological Reviews 58 (2006) 621-681
6. Faundez M., Pino L., Letelier P., Ortiz C., Lopez R., Seguel C., Ferreira J., Pavani M., Morello A., and Maya J.D. Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy 49 (2005) 126-130
7. Ferreira V., Valck C., Sanchez G., Gingras A., Tzima S., Molina M.C., Sim R., Schwaeble W., and Ferreira A. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. Journal of Immunology 172 (2004) 3042-3050
8. Freire-de-Lima C.G., Nascimento D.O., Soares M.B., Bozza P.T., Castro-Faria-Neto H.C., de Mello F.G., DosReis G.A., and Lopes M.F. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403 (2000) 199-203
9. Freire-de-Lima C.G., Xiao Y.Q., Gardai S.J., Bratton D.L., Schiemann W.P., and Henson P.M. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. Journal of Biological Chemistry 281 (2006) 38376-38384
10. Hideko Tatakihara V.L., Cecchini R., Borges C.L., Malvezi A.D., Graca-de Souza V.K., Yamada-Ogatta S.F., Rizzo L.V., and Pinge-Filho P. Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection. FEMS Immunology and Medical Microbiology 52 (2008) 47-58
11. Jia J., Zhu F., Ma X., Cao Z., Li Y., and Chen Y.Z. Mechanisms of drug combinations: interaction and network perspectives. Nature Reviews. Drug Discovery 8 (2009) 111-128
12. Keystone E.C., Paton T.W., Littlejohn G., Verdejo A., Piper S., Wright L.A., and Goldsmith C.H. Steady-state plasma levels of salicylate in patients with rheumatoid arthritis: effects of dosing interval and tablet strength. Canadian Medical Association Journal 127 (1982) 283-286
13. Kubata B.K., Kabututu Z., Nozaki T., Munday C.J., Fukuzumi S., Ohkubo K., Lazarus M., Maruyama T., Martin S.K., Duszenko M., and Urade Y. A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. Journal of Experimental Medicine 196 (2002) 1241-1251
14. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., and Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annual Review of Immunology 24 (2006) 99-146
15. Maya J.D., Cassels B.K., Iturriaga-Vasquez P., Ferreira J., Faundez M., Galanti N., Ferreira A., and Morello A. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 146 (2007) 601-620
16. Michelin M.A., Silva J.S., and Cunha F.Q. Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Experimental Parasitology 111 (2005) 71-79
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65 (1983) 55-63
18. + T lymphocytes from infected hosts. Journal of Immunology 160 (1998) 1313-1319
19. Paiva C.N., Arras R.H., Lessa L.P., Gibaldi D., Alves L., Metz C.N., Gazzinelli R., Pyrrho A.S., Lannes-Vieira J., and Bozza M.T. Unraveling the lethal synergism between Trypanosoma cruzi infection and LPS: a role for increased macrophage reactivity. European Journal of Immunology 37 (2007) 1355-1364
20. Peluffo G., Piacenza L., Irigoin F., Alvarez M.N., and Radi R. l-Arginine metabolism during interaction of Trypanosoma cruzi with host cells. Trends in Parasitology 20 (2004) 363-369
21. Pinge-Filho P., Tadokoro C.E., and Abrahamsohn I.A. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cellular Immunology 193 (1999) 90-98
22. Reithinger R., Tarleton R.L., Urbina J.A., Kitron U., and Gurtler R.E. Eliminating Chagas disease: challenges and a roadmap. British Medical Journal 338 (2009) b1283
23. Tsikas D. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the l-arginine/nitric oxide area of research. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 851 (2007) 51-70